| 16 |
NIRS-IVUS: Imaging to Guide Optimal PCI |
James A. Goldstein |
Apr. 21. 16 |
| 15 |
[Interesting Image Case Reviews] NIRS |
Jun Ho Lim |
Dec. 08. 15 |
| 14 |
Vulnerable Plaque Detection by Grayscale IVUS and NIRS |
Akiko Maehara |
Dec. 08. 15 |
| 13 |
NIR Imaging in the Cath Lab: When & How |
Joon Won Kang |
Apr. 21. 15 |
| 12 |
Will Combined IVUS-NIRS Imaging Improve Our Ability to Predict Culprit Lesions? |
James E. Muller |
Apr. 21. 15 |
| 11 |
How to Assess Biological Activity of Inflammarory Plaque?: Combined OFDI-NIRF Molecular Imaging |
Jin Won Kim |
Apr. 21. 15 |
| 10 |
Clinical Trials by Using NIRS: Clinical Relevance and Prognostic Implication |
Akiko Maehara |
Apr. 21. 15 |
| 9 |
NIR: PROSPECT II and PROSPECT ABSORB Trial |
Akiko Maehara |
Dec. 09. 14 |
| 8 |
NIRS-IVUS to Predict Long Term Outcome |
Akiko Maehara |
Dec. 09. 14 |
| 7 |
NIRS vs. IVUS: Lessons from in Vivo ACS Patients and in Vitro SCD Cases |
Jun Pu |
Dec. 09. 14 |
